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now clearly established, subsequent trials 
should directly compare other new thera-
peutic agents with tacrolimus, or system-
atically evaluate the addition of a second 
agent to maintain remission and abbreviate 
the duration of tacrolimus therapy. In addi-
tion, subsequent prospective trials of pedi-
atric SRNS should specifically stratify 
patients according to histopathology and 
potential biomarkers, 13 and also perform 
targeted genotyping for all currently recog-
nized genetic causes of SRNS. Such an 
approach will enable the development of a 
more personalized and eff ective therapeutic 
strategy for this vexing disease. 
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 A defect in vasopressin secretion 
in autosomal dominant 
polycystic kidney disease 
 Daniel G.  Bichet 1 
 A nephrogenic defect in urine concentration is well established in 
patients with polycystic kidney disease, but Ho  et al. report a defect in 
the increase of plasma vasopressin in response to dehydration. 
On a cellular level, transient receptor potential channels responsible for 
osmoperception could interact with TRPPs encoded by the polycystic 
genes  PKD1 and  PKD2 . 
 Kidney International (2012)  82, 1051 – 1053.  doi: 10.1038/ki.2012.271 
 Ho  et al. , 1 in this issue of  Kidney Interna-
tional , demonstrate that autosomal domi-
nant polycystic kidney disease (ADPKD) 
is associated not only with lower urinary 
osmolality but also with less vasopressin 
secretion. As PKD gene expression has 
been found in hypothalamic nuclei, these 
clinical observations suggest a specifi c role 
of PKD genes in osmoregulation. 
 A defect in renal concentrating 
capacity is well demonstrated in 
polycystic kidney disease 
 Martinez-Maldonado  et al. 2 published as 
early as 1972 that the inability to concentrate 
urine was a common fi nding both in chro-
nic kidney disease and in polycystic kidney 
disease (PKD). However, the urinary con-
centration defect was observed in ADPKD 
patients with normal renal function 3 and 
was probably related to physical alterations 
of the renal medulla by cysts originating in 
the collecting duct, principally the cortico-
medullary junction. In these early studies, 
an inverse correlation was demonstrated 
between urinary osmolality and renal 
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volume estimated by ultrasound. Measure-
ment of maximal urine osmolality aft er 
an overnight dehydration was then pro-
posed as an inexpensive way to screen for 
ADPKD as compared with the more costly 
renal ultrasound. 3 
 The new fi ndings of Ho  et al. : defective 
vasopressin release in patients with 
ADPKD 
 In the study by Ho  et al. , 1 adults and 
children with ADPKD were matched 
with unaff ected family members and 
demonstrated higher plasma osmolality 
and lower urinary osmolality (710 ver-
sus 920  mosmol / kg H 2 O) in response to 
dehy dration. Plasma vasopressin levels 
remained unchanged in adult ADPKD 
patients, contrasting with increased val-
ues in controls. Th ese vasopressin levels 
are critical, as patients with hereditary or 
acquired nephrogenic diabetes insipidus 
always have higher plasma vasopressin 
values. 4 
 Expression of  PKD1 and  PKD2 genes 
in the Allen Mouse and Human Brain 
Atlases 
 Th e Allen Institute for Brain Science, 
established in 2003 by Paul Allen (one of 
the original founders of Microsoft ), set out 
to describe the expression of all known 
genes in the adult mouse brain, 5,6 and 
colorimetric  in situ hybridization data for 
21,000 genes are now posted online with 
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open access. Ho  et al. 1 determined that 
the transcripts of  Avp (the gene coding for 
vasopressin) as well as  Pkd1 and  Pkd2 were 
clearly enriched in paraventricular, supra-
chiasmatic, and supraoptic hypothalamic 
nuclei known to produce vasopressin. Th e 
resolution of the Allen Brain Atlas is  ‘ quasi-
cellular ’ : it is not possible to deter mine 
colocalization in the same vasopressin-
producing magnocellular cells, but fi gures 
from the article of Ho  et al. , 1 are convinc-
ing. As Koester and Insel 7 have commented, 
it will be important in future Allen Institute 
for Brain Science initiatives to combine 
microarray analysis with electrophysiology 8 
and neurotransmitter immunochemistry to 
describe the exact interactions between 
PKD1 / 2 and TRPVs (transient receptor 
potential vanilloid-type) in magnocellular 
cells producing vasopressin or in other osmo-
regu latory neurons of the subfornical organ, 
the organum vasculosum of the lamina ter-
minalis, and the median preoptic nucleus. 8 
 Possible interactions between 
polycystin-1, polycystin-2, and 
TRPV proteins responsible for 
osmoregulation 
 Polycystin-1 (encoded by  PKD1 , the gene 
responsible for polycystic kidney disease 
type 1) and polycystin-2 ( PKD2 ) are ex-
pressed in the kidney and are responsible 
for ADPKD: TRPP2 (PKD2) is a six-
transmembrane-domain protein that may 
form a Ca   +   +   permeable cation channel in 
association with TRPP1 (polycystin-1, or 
PKD1). TRPP1 and TRPP2 are members 
of the large family of transient receptor 
potential channels (reviewed by Nilius 9 ). 
In addition to renal epithelial cells, poly-
cystins are also abundantly expressed in 
the myocytes of the blood vessels, where 
they may have a role in pressure sensing. 10 
Kottgen  et al. 11 used transfected MDCK or 
HEK 293 cells to demonstrate that TRPP2 
(polycystin-2) engages in a heteromeric 
interaction with the TRPV4 channel to 
form a mechanical and thermosensitive 
molecular sensor. Heteromeric mem-
brane receptors 12 and membrane chan-
nels, inclu ding transient receptor potential 
channels, 13 are an active area of research. 
Th e diversity of function and regula-
tion obtained through heteromeric inter-
actions is potentially large; for example, an 
aquaporin-4 / transient receptor potential 
vanilloid 4 (AQP4 / TRPV4) complex has 
been found to be essential for volume con-
trol in astrocytes. 14 
 TRPV1 expressed centrally in supra-
optic and paraventricular magnocellular 
cells or TRPV4 expressed in peripheral 
portal neurons sensing portal vein osmo-
lality could form heteromeric units with 
TRPP2 (PKD2) and decrease vasopressin 
production when  PKD1 or  PKD2 is 
mutated (remember that TRPP2 forms 
a functional complex with TRPP1). 
 Regulation of vasopressin by tonicity 
information relayed by central 
osmoreceptor neurons expressing 
TRPV1 and peripheral osmoreceptor 
neurons expressing TRPV4 
 As summarized elegantly by Bourque, 8 
early studies provided clear evidence 
that  ‘ cellular dehydration ’ (that is, cell 
shrinking) was required for thirst and 
vasopressin release to be stimulated 
during extracellular fl uid hyperosmola-
lity: these responses could be induced by 
infusions of concentrated solutions con-
taining membrane-impermeable solutes, 
which extract water from cells, but not 
by infusions of solutes that readily equili-
brate across the cell membrane (such 
as urea). Verney coined the term  ‘ osmo-
receptor ’ to designate the specialized 
sensory elements. He further showed that 
these were present in the brain and pos-
tulated that they might comprise  ‘ tiny 
osmometers ’ and  ‘ stretch receptors ’ that 
would allow osmotic stimuli to be  ‘ trans-
muted into electrical ’ signals. 15 Osmore-
ceptors are therefore defi ned functional-
ly as neurons endowed with an intrinsic 
ability to detect changes in extracellular 
fl uid tonicity, and it is now known that 
both cerebral ( Figure 1 ) and peripheral 
osmoreceptors 16 contribute to the body 
fl uid balance. 
 The cellular basis for osmoreceptor 
potentials has been characterized by patch-
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 Figure 1  |  Osmoreception in hypothalamic vasopressin neurons. Changes in osmolality cause 
inversely proportional changes in soma volume. Shrinkage activates nonselective cation channels 
(NSCCs), and the ensuing depolarization increases action potential firing rate and vasopressin (VP) 
release from axon terminals in the neurohypophysis. Increased vasopressin levels in blood enhance 
water reabsorption by the kidney (antidiuresis) to restore extracellular fluid osmolality toward the 
set point. Hypotonic stimuli inhibit NSCCs. The resulting hyperpolarization and inhibition of firing 
reduce vasopressin release and promote diuresis. The lack of osmotic stimulation of vasopressin 
observed in the polycystic kidney disease patients described by Ho  et al. 1 might be attributable 
to heteromeric NSCC / TRPP2 channels. In the figure, the NSCCs are represented at the surface of 
magnocellular cells producing vasopressin with positive ions Ca   +   +   and Na   +   entering the cells. 
They could form heteromers with mutated  TRPP2 in PKD patients and result in less vasopressin 
produced for the same osmotic stimulus. Heteromeric TRPV4 / TRPP2 could also exist in peripheral 
neurons acting as tonoreceptors in the portal vein (not schematized here) (adapted from ref.  23). 
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clamp recordings and morphometric anal-
ysis in magnocellular cells isolated from 
the supraoptic nucleus of the adult rat. In 
these cells, stretch-inactivating cationic 
channels transduce osmotically evoked 
changes in cell volume into functionally 
relevant changes in membrane potential. 
Magnocellular neurons also operate as 
intrinsic Na   +   detectors. Th e N-terminal 
variant of the transient receptor potential 
channel (TRPV1) is an osmotically acti-
vated channel expressed in magnocellular 
cells that produce vasopressin and in the 
circumventricular organs, the organum 
vasculosum of the lamina terminalis, and 
the subfornical organ. 8 Since osmoregula-
tion still operates in  Trpv1   −  /  −   mice, other 
osmosensitive neurons or pathways must 
be able to compensate for loss of central 
osmoreceptor function. Aff erent neurons 
expressing the osmotically activated ion 
channel TRPV4 in the thoracic dorsal root 
ganglia that innervate hepatic blood vessels 
and detect physiological hypo-osmotic 
shift s in blood osmolality have recently 
been identified. 16 In mice lacking the 
osmotically activated ion channel TRPV4, 
hepatic sensory neurons no longer exhibit 
osmosensitive inward currents, and activa-
tion of peripheral osmoreceptors  in vivo 
is abolished. In a large cohort of human 
recipients of liver transplants, who presum-
ably have denervated livers, plasma osmo-
lality is signifi cantly elevated compared 
with that in healthy controls, suggesting 
the presence of an inhibitory vasopressin 
eff ect of hyponatremia, perceived in the 
portal vein from hepatic afferents. 16 
TRPV1 (expressed in central neurons) and 
TRPV4 (expressed in peripheral neurons) 
thus appear to play entirely comple mentary 
roles in osmoreception. Note that TRPV4 
expression seems to be more important 
peripherally than centrally, since hyper-
tonicity sensing in the organum vasculo-
sum of the lamina terminalis is a 
mecha nical process involving TRPV1 but 
not TRPV4. 17 
 A defect in vasopressin secretion in 
response to dehydration might be 
benefi cial to ADPKD patients 
 Approximately 600,000 people in the 
United States have ADPKD, and vaso-
pressin is a potent activator of adenylyl 
cyclase in collecting duct cells that consti-
tute most of the cysts in ADPKD. When 
PCK rats and Brattleboro ( Avp   −  /  −   ) rats 
(rats with autosomal recessive central dia-
betes insipi dus) were crossed, a complete 
inhibition of cystogenesis was observed 
in PCK  Avp   −  /  −   rats, demonstrating that 
vasopressin directly regulates cyst growth 
in PKD. 18 Also, in a recent study in 
which 63 ADPKD subjects were ran-
domly matched 1:2 to historical controls 
by sex, hypertension, age, and baseline to-
tal kidney volume (assessed by magnetic 
resonance imaging) and thrice-annual 
estimated glomerular fi ltration rate, ADP-
KD cyst growth progressed more slowly 
with tolvaptan, a non-peptide vasopressin 
V2 receptor antagonist, than in historical 
controls. 19 It is not known whether less 
vasopressin is pro duced in response to 
vasopressin V2 receptor antagonism in 
ADPKD patients as compared with nor-
mal subjects. Elevated intracellular cyclic 
adenosine monophosphate, in response 
to vasopressin, occurs in some forms of 
PKD and is known to contribute to cyst 
formation, in part by stimulating prolifer-
ative activity of cyst epithelial cells. 18,20,21 
Also, apical mislocalization of vasopressin 
type 2 receptor to the apical membrane in 
PKD collecting duct cells could increase 
salt and water transport through aqua-
porin-2 water channels and epithelial 
sodium channels expressed in the same 
cells. 22 Whether such apical vasopressin 
type 2 receptor localization contributes to 
enhanced fl uid retention and hyperten-
sion in PKD remains to be determined. 
 In summary, there is defective vaso-
pressin production in response to dehy-
dration in PKD patients that may be 
explained by a direct interaction between 
TRPP and TRPV channels. Th is observa-
tion might be clinically applied to increase 
urine fl ow in PKD patients and potentially 
retard cyst formation. 
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